Technically Speakin...
Health Care: Health Services
BioMimetic Therapeutics Inc. (BMTI: NASDAQ)
$2.49 -0.03 | -1.19%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 18.50M | 11.63M | 21.54M | 17.53M |
| Receivables | 1.21M | 476.43K | 690.02K | 11.64M |
| Inventories | 3.53M | 2.26M | 1.04M | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 66.67M | 80.70M | 70.93M | 62.89M |
| Property, Plant & Equipment, Gross | 12.68M | 13.71M | 13.20M | 10.78M |
| Accumulated Depreciation & Depletion | 7.38M | 6.12M | 5.04M | 3.77M |
| Property, Plant & Equipment, Net | 5.30M | 7.59M | 8.16M | 7.01M |
| Intangibles | 2.44M | 1.87M | 2.92M | 4.98M |
| Other Non-Current Assets | 463.38K | 15.39M | 6.90M | 50.23M |
| Total Non-Current Assets | 8.21M | 24.85M | 17.99M | 62.23M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 74.89M | 105.55M | 88.91M | 125.12M |
| Accounts Payable | 2.46M | 1.67M | 2.26M | 4.33M |
| Short Term Debt | 83.92K | 78.66K | 56.52K | 18.19K |
| Other Current Liabilities | 17.19K | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 6.52M | 7.22M | 5.72M | 10.01M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 39.10M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 14.23M | 15.00M | 15.97M | 16.92M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 14.36M | 15.21M | 16.14M | 56.05M |
| Total Liabilities | 20.87M | 22.43M | 21.86M | 66.07M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 54.01M | 83.12M | 67.05M | 59.05M |
| Common Par | 28.13K | 27.93K | 21.82K | 18.71K |
| Additional Paid In Capital | 214.63M | 210.55M | 160.53M | 131.26M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -160.65M | -127.46M | -93.52M | -72.36M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 4.49K | -2.46K | 17.39K | 135.54K |
| Total Capitalization | 54.01M | 83.12M | 67.05M | 98.15M |
| Total Equity | 54.01M | 83.12M | 67.05M | 59.05M |
| Total Liabilities & Stock Equity | 74.89M | 105.55M | 88.91M | 125.12M |
| Total Common Shares Outstanding | 28.13M | 27.93M | 21.83M | 18.71M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 28.00M | 24.63M | 20.51M | 18.53M |
| Diluted Weighted Shares Outstanding | 28.00M | 24.63M | 20.51M | 18.53M |
| Number of Employees | 75 | 95 | 89 | 88 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with BMTI
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- Usertest
- ContributorBarron's Activist Stocks 12...
- Userjcweddell Portfolio 1
- Userrazzmazz Portfolio 1
- ContributorBarron's Activist Stocks 7-...
- ContributorBarron's Insider Purchases ...
- Useramarmaharaj Portfolio 1
- UserGet this thing started
- UserBREAKOUTS2008
Latest BMTI Headlines from TheStreet
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.27.11 | 04:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.19.11 | 12:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.11.11 | 11:07 am
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.01.11 | 12:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 06.23.11 | 11:06 am
- BioMimetic Stock Hits New 52-Week Low (BMTI) 06.08.11 | 12:06 pm
- BioMimetic Stock Falls On Unusually High Volume (BMTI) 05.13.11 | 10:05 am
- BioMimetic Stock Gaps Down On Today's Open (BMTI) 05.10.11 | 09:05 am
- Insiders Buy and Sell RealD IPO 07.20.10 | 09:07 am
- Stock Offerings: First of Long Island 07.15.10 | 09:07 am
Press Releases for BMTI
- BioMimetic Therapeutics, Inc. Reports First Quarter 2012 Earnings Results - Business Wire 05.09.12 | 04:05 pm
- BioMimetic Therapeutics, Inc. To Report First Quarter 2012 Financial Results On May 9 - Business Wire 05.07.12 | 11:05 am
- BioMimetic Therapeutics, Inc. Reports Fourth Quarter And Year-End 2011 Earnings Results - Business Wire 03.13.12 | 04:03 pm
- BioMimetic Therapeutics, Inc. To Report 2011 Fourth Quarter And Year-End Financial Results On March 13 - Business Wire 03.09.12 | 02:03 pm
- BioMimetic Therapeutics, Inc. To Introduce Augmatrix™ Biocomposite Bone Graft Product Line At AAOS - Business Wire 02.08.12 | 09:02 am
- BioMimetic Therapeutics, Inc. To Highlight Product Development Activities At ORS And AAOS Meetings - Business Wire 02.06.12 | 04:02 pm
- BioMimetic Therapeutics, Inc. To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.10.12 | 11:01 am
- BioMimetic Therapeutics Announces Approval To Market GEM 21S® In The European Union - Business Wire 01.03.12 | 04:01 pm
- BioMimetic Therapeutics Receives Augment® Bone Graft PMA Response Letter From FDA - Business Wire 01.03.12 | 04:01 pm
- BioMimetic Therapeutics, Inc. Reports Third Quarter 2011 Earnings Results - Business Wire 11.08.11 | 04:11 pm
Partner Headlines for BMTI
- Speculative Biotech: A Speculation Trader's Dream and Nightmare - Seeking Alpha 11.03.11 | 09:11 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Morning Market Losers (BMTI, NSPH, HEAT, PAL) - Benzinga 05.10.11 | 09:05 am
- 9 Healthcare Companies Expecting May Catalysts - Seeking Alpha 05.04.11 | 08:05 am
- BioMimetic: What the Bulls Are Seeing - Seeking Alpha 03.18.11 | 08:03 am
- Early-Market Movers: Vivus, Amedisys - Fox Business 07.13.10 | 09:07 am
